Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress
10 months ago
By
In InvestmentsVenture Capital
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
10 months ago
By
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
10 months ago
By
In Biopharma HighlightsClinical TrialsInnovationInvestments
Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools
12 months ago
By
In AI & DataInvestments
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial
1 year ago
By
In InvestmentsPeopleVenture Capital
Big Bets and Strategic Moves Drive Biotech Investment in 2025
1 year ago
By
In InvestmentsLeadersPartnerships
Eli Lilly’s $27 Billion Investment Highlights Surge in Biotech Funding and Strategic Partnerships
1 year ago
By
In DealsInvestmentsPeople
Takeda Seals Major $770 Million Drug Design Partnership While Other Biotech Firms Secure Vital Financing
1 year ago
By
In Funding RoundsInvestmentsPeopleVenture Capital
1 year ago
By
In InvestmentsVenture Capital
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships
1 year ago
By
In DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences
1 year ago
By
In AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Atalanta Therapeutics Secures $97M Series B to Advance RNAi Treatments for Epilepsy and Huntington’s Disease
1 year ago
By
In Clinical TrialsInvestmentsPartnershipsResearch UpdatesVenture Capital
North America Leads January Biotech Funding Round with Nearly $2 Billion Raised, Oncology and Obesity Startups Dominate
1 year ago
By
In Breaking NewsInvestmentsPartnershipsVenture Capital
Survey Reveals Clinicians Feel Ill-Prepared for Sex Differences in Disease Despite Frequent Observations
1 year ago
By
In Industry ConferencesInvestmentsPeopleTop Stories
Neumora’s Depression Drug Stumbles in Pivotal Phase 3, Stock Plummets Over 80%
1 year ago
By
In Clinical TrialsInvestmentsResearch UpdatesTop Stories
New Venture Capital Firms Step In to Fuel Clinical Research Amid Biotech Funding Shift
1 year ago
By
In Funding RoundsInvestmentsPeopleVenture Capital
Cellarity’s AI-Designed Cell Therapy Enters Phase 1 for Solid Tumors, Backed by $250M Series D
1 year ago
By
In Biopharma HighlightsClinical TrialsInvestmentsVenture Capital
Celosia Therapeutics Raises $16.75M to Advance Gene Therapy for ALS
1 year ago
By
In BreakthroughsInvestmentsPartnerships
Strand Therapeutics Raises $153M to Advance mRNA Cancer Therapies
1 year ago
By
In InvestmentsPeopleResearch Updates
AI-Powered Drug Discovery Accelerates Biopharma Innovation and Reduces R&D Costs
2 years ago
By
In Featured AnalysisInvestmentsPartnershipsResearch UpdatesTechnologyTop Stories
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS
2 years ago
By
In FDA ApprovalsInvestmentsPharma Industry Updates